CN1062144C - Yisuishengxue chinese medicine preparation for tonifying marrow and promoting generation of blood - Google Patents
Yisuishengxue chinese medicine preparation for tonifying marrow and promoting generation of blood Download PDFInfo
- Publication number
- CN1062144C CN1062144C CN95110503A CN95110503A CN1062144C CN 1062144 C CN1062144 C CN 1062144C CN 95110503 A CN95110503 A CN 95110503A CN 95110503 A CN95110503 A CN 95110503A CN 1062144 C CN1062144 C CN 1062144C
- Authority
- CN
- China
- Prior art keywords
- radix
- blood
- chinese medicine
- present
- colla
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to a Chinese medicine preparation for benefiting marrow and supplying blood. The present invention has the efficiency of replenishing qi to invigorate the spleen, nourishing kidney to benefit marrow, supplying blood, nourishing blood, removing blood stasis for promoting tissue regeneration, clearing heat for detoxifying, strengthening body resistance and resisting pathogenic factors, and has the functions of promoting marrow hematopoiesis, increasing blood cells and haemoglobin, promoting the synthesis of DNA, regulating humoral immunity and cell immunity of organism, etc. The prescription of the present invention is strict, and the present invention has obvious curative effects on treating myeloproliferative disorder syndrome and all classes of anemia; the total effective rate is up to 91.7%, and the recurernce rate is low. The present invention comprises the main components: codonopsis pilosula, cornus, glue of tortoise plastron, turtle shell, morinda root, deerhorn glue, angelica, spatholobus stem, hairyvein agrimonia herd and natural indigo.
Description
The present invention relates to a kind of Chinese medicine preparation for the treatment of myelodysplastic syndrome.
Myelodysplastic syndrome (be called for short MDS), be one group of refractory anemia or with other cytopenia the disorderly syndrome of heterogeneity hemopoietic function of myeloproliferative disorder.Described one group of refractory anemia has (1) refractory anemia type (RA): (RA-S): (3) refractory anemia with excess of blasts type (RAEB): (4) refractory anemia with excess of blasts is at transition phase type (RAEB-T) for (2) refractory anemia companion ring-type sideroblast type, MDS is often because of infection, hemorrhage or dead to the acute myeloid leukaemia conversion, be that current hematology worker both at home and abroad pays close attention to most and need one of assistant officer's difficult disease to be studied the countermeasure, tackling key problem disease, both at home and abroad to the treatment shortage produce effects medicine of MDS, radical cure does not more have good method at present.Existing conventional hematopoietic curative effect is not remarkable, adrenocortical hormone, androgen and chemotherapeutics not only effect are undesirable, and toxic and side effects is bigger, not only kill and wound normal hemocyte, reduce the function of exempting from service, cause infecting and hemorrhage chance increases, and cause easily that a sodium water small piece of land surrounded by water is stayed, blood pressure increases, blood glucose metabolism disorder and cause iatrogenic diabetes etc.In recent years, adopt the bone marrow transplantation therapy better, but, be difficult to popularize because of being subjected to the restriction of economic condition and medical condition to the MDS curative effect.Beijing College of Traditional Chinese Medicine, adopting " supplementing QI and nourishing YIN activating blood circulation method " to take Chinese medicine benefit marrow spirit treatment 32, example is clinical now examines, and its total effective rate is 81.25%, though certain effect has been arranged, its curative effect is also undesirable.
The purpose of this invention is to provide a kind of Chinese medicine preparation, have curative effect height, relapse rate low, have no side effect cheap characteristics.
A kind of Chinese medicine preparation of beneficial marrow hemopoietic has been realized above-mentioned purpose, and it comprises the medicine of following five class effects:
(1) replenishing QI to invigorate the spleen: Radix Ginseng Rubra or Radix Codonopsis.
(2) nourishing YIN and supplementing blood: Fructus Corni, Colla Plastri Testudinis (or Carapax et Plastrum Testudinis), Carapax Trionycis,
(3) beneficial marrow tonifying YANG: Radix Morindae Officinalis,
(4) blood-supplementing blood-nourishing: Colla cornus cervi (or Cornu Cervi Pantotrichum), Radix Angelicae Sinensis,
(5) promoting blood circulation and hemostasis: Caulis Spatholobi, Herba Agrimoniae.
The present invention is based on 9 kinds of components of above-mentioned five class effects, and the medicine of every class effect can also be again and other medicine compatibility of this apoplexy due to endogenous wind, and according to drug effect, other each relatively more suitable component is:
(1) replenishing QI to invigorate the spleen: the Radix Astragali, Rhizoma Atractylodis Macrocephalae (parched), Rhizoma Dioscoreae, Poria, wherein 2~3 kinds, the preferred Radix Astragali, Rhizoma Atractylodis Macrocephalae (parched);
(2) nourishing YIN and supplementing blood: Fructus Ligustri Lucidi, Radix Rehmanniae Preparata, Rhizoma Polygonati, Fructus Lycii, two mulberry, Herba Ecliptae, Radix Ophiopogonis, wherein 2~3 kinds, preferred Fructus Ligustri Lucidi, Radix Rehmanniae Preparata;
(3) beneficial marrow tonifying YANG: Cortex Cinnamomi, Herba Epimedii, Semen Cuscutae, Rhizoma Curculiginis, wherein 2~3 kinds, preferred Cortex Cinnamomi, Herba Epimedii;
(4) blood-supplementing blood-nourishing: in Colla Corii Asini, Radix Polygoni Multiflori, the Arillus Longan 1~3 kind, preferred Colla Corii Asini, Radix Polygoni Multiflori;
(5) promoting blood circulation and hemostasis: in Radix Notoginseng, the Pseudobulbus Bletillae (Rhizoma Bletillae), Radix Rubiae, Nodus Nelumbinis Rhizomatis, Folium Artemisiae Argyi, Crinis Carbonisatus, brown charcoal, side uncle charcoal, the Herba Cirsii 1~3 kind, preferred Radix Notoginseng.
The present invention can also add the antipyretic and antidotal type medicine, is selected from 1~3 kind in Indigo Naturalis, Hedyotidis Diffusae, Herba Scutellariae Barbatae, Rhizoma Polygoni Cuspidati, the Pseudobulbus Cremastrae Seu Pleiones, preferred Indigo Naturalis.Such medicine adds the MDS of transition phase type disease in more serious refractory anemia with excess of blasts type of treatment and refractory anemia with excess of blasts, and the anemia of other type can not added, and is only favourable in addition and have no adverse effects.
The present invention has wherein adopted YIN nourishing and warming YANG class medicine, focus on tonifying both YIN and YANG, and selection has active strong component, play replenishing QI to invigorate the spleen, nourishing kidney benefit marrow, passage, nourishing blood, promoting tissue regeneration by removing blood stasis, heat-clearing and toxic substances removing altogether, set upright the effect that resists heresy, kidney essense Sheng, change source foot, negative and positive coordination, anemia are cured, therefore make the present invention have unique curative effect.
Through pharmacological research and clinical observation, each Chinese medicinal components of selection is when participating in compatibility, when selecting following consumption the most effectively (referring to the crude drug consumption, in parts by weight):
Radix Ginseng Rubra 5~20 (or Radix Codonopsis 10~30), the Radix Astragali 10~60, Rhizoma Atractylodis Macrocephalae (parched) 5~20, Rhizoma Dioscoreae 10~30, Poria 10~30, Fructus Corni 10~30, Colla Plastri Testudinis 10~20 (or Carapax et Plastrum Testudinis 10~30), Carapax Trionycis 10~30, Fructus Ligustri Lucidi 10~30, Radix Rehmanniae Preparata 10~30, Rhizoma Polygonati 10~30, Fructus Lycii 10~30, two mulberrys 10~30, Herba Ecliptae 10~30, Radix Ophiopogonis 10~15, Radix Morindae Officinalis 10~20, Cortex Cinnamomi 3~10, Herba Epimedii 10~30, Semen Cuscutae 10~30, Rhizoma Curculiginis 10~20, Colla cornus cervi 10~20 (or Cornu Cervi Pantotrichum 5~10), Radix Angelicae Sinensis 10~30, Colla Corii Asini 10~20, Radix Polygoni Multiflori 10~15, Arillus Longan 10~20, Caulis Spatholobi 10~30, Radix Notoginseng 2~10, the Pseudobulbus Bletillae (Rhizoma Bletillae) 10~20, Radix Rubiae 10~30, Nodus Nelumbinis Rhizomatis 10~30, Folium Artemisiae Argyi, Crinis Carbonisatus, the palm fibre charcoal, side uncle charcoal Herba Cirsii each 10~30.The amount that is higher than each component does not improve curative effect, is lower than its amount and just can lessens the curative effect.
Best group of the present invention becomes:
Radix Ginseng Rubra 15 (or Radix Codonopsis 30), the Radix Astragali 50, Rhizoma Atractylodis Macrocephalae (parched) 15, Fructus Corni 20, Colla Plastri Testudinis 20 (or Carapax et Plastrum Testudinis 30), Carapax Trionycis 20, Fructus Ligustri Lucidi 30, Radix Rehmanniae Preparata 30, Radix Morindae Officinalis 15, Cortex Cinnamomi 6, Herba Epimedii 18, Colla cornus cervi 20 (or Cornu Cervi Pantotrichum 5), Radix Angelicae Sinensis 20, Colla Corii Asini 20, Caulis Spatholobi 30, Herba Agrimoniae 30, Radix Notoginseng 5, Indigo Naturalis 4.
Wherein the Radix Codonopsis drug effect is lower than Radix Ginseng Rubra, and the Carapax et Plastrum Testudinis drug effect is lower than Colla Plastri Testudinis, and the Colla cornus cervi effect is lower than Cornu Cervi Pantotrichum, but Cornu Cervi Pantotrichum medicine source deficiency costs an arm and a leg, and Colla cornus cervi can be alternative fully.This best prescription prescription is tight, concise, drug effect is best.
Best dosage form of the present invention is a pill, taking convenience, and its manufacture method is the preparation method of Chinese patent medicine pill routinely, each Chinese medicinal components concocting method routinely.Also can make other dosage form according to a conventional method, as mixture, tablet etc.
By treating 65 routine patients' clinical observation, total effective rate is 91.7%, obvious effective rate 75%, and relapse rate is low, to its modern pharmacology analysis and research, have promote bone marrow hematogenesis, promote hemocyte and hemoglobin, promotion DNA synthetic, regulate effects such as humoral immunity of organism and cellular immunization, not only treat the MDS special effect, all kinds of anemia disease 816 examples (as aplastic anemia, leukemia, immune hemolytic anemia, iron deficiency anemia, megaloblastic anemia zither) are also had significant curative effect.Because of having, it improves and the adjusting immunization, so some immunodeficiency diseases is also had therapeutical effect preferably, the old people had the health-care effect that anti-ageing labor fills blood, cause is Chinese herbal and crude drugs preparations sheerly, have no side effect, taking convenience, and also cheap, MDS provides a kind of specially good effect good medicine for treatment, all has unique curative effect than other Chinese medicine.
Case one:
Old XX, the woman, 50 years old, the cotton mill cadre of Urumqi City, Xinjiang, weak 2 years of the painful dizzy companion of the excuse whole body is surplus, increases the weight of half a year, examines on August 10th, 92.The dizzy headache of the self-induction of patient's unknown cause before 2 years, complexion is gradually yellow, the whole body is weak, once removed ground hospital admissions such as Urumqi City and Beijing, Tianjin, be diagnosed as MDS-RA, gave blood transfusion repeatedly through looking into bone marrow smear, oral stanozolol, revolving medicine treatments such as azoles and retinoic acid, effect does not show, and the present, I went to a doctor at institute.Have a medical check-up: the anemia looks, pale tongue, tongue is white, deep and weak pulse is unable, and blood test is conventional result show: Hb35g/L RBC1.13 * 10
12/ L PC
50* 10
9/ L, Western medicine diagnose: MDS-RA, tcm diagnosis: asthenia, dialectical: deficiency of spleen and stomach, insufficiency of vital energy and blood, give oral beneficial marrow SHENGXUE WAN, each 6g, day clothes three times cooperate stanozolol, Theragran and blood transfusion Supporting Therapy, after three months (courses of treatment), patient's diet increases, dizzy headache transference cure, and the whole body is more preceding strong.The check routine blood test is the result show: Hb56g/L RBC2.56 * 10
12/ L WBC2.3 * 10
9/ L PC76 * 10
9/ L, after clothes this medicine treatment (blood transfusion again) three courses of treatment, all cards of patient disappear, and have rosy cheeks, and the check routine blood test is the result show: Hb112g/L RBC4.26 * 10
12/ L WBC4.2 * 10
9/ L PC82 * 10
9/ L, the beneficial marrow SHENGXUE WAN of clothes that continues is consolidated curative effect, follows up a case by regular visits to and does not have recurrence in 1 year.
Case two:
Open XX, man, 24 years old, Manzhouli, Inner Mongol frontier guard, because of suffering from acute lymphoblastic leukemia (L2) 5 months, exhale city hospital combined chemotherapy through living the locality, change tens of chemotherapy regimens repeatedly, the commentaries on classics but the state of an illness is not got better, bone marrow smear fail to alleviate all the time, and leukocyte reduces to 0.3 * 10
9/ L was forced to interrupt chemotherapy, is decided to be the impatient pouring of refractory, lived my institute on June 14th, 94.Have a medical check-up: young man, pale tongue with white fur, thready and weak pulse, Western medicine diagnose: intractable acute lymphoblastic leukemia, tcm diagnosis: asthenia.Looking into the bone marrow smear result after being admitted to hospital shows: the children drenches 58.5%, promptly gives beneficial marrow SHENGXUE WAN oral, each 6g, day obeys three times, treated one month, the check bone marrow smear is the result show: the children drenches 45%, adds medicine to treatment after three months continue clothes, the all diseases of patient disappear, have rosy cheeks, the check bone marrow smear is the result show: alleviate (children drenches 3%) fully, do not use any chemotherapeutics during the hospitalization, the clothes that continue are added medicine to, and follow up a case by regular visits to and do not recur half a year.
Case three:
Open XX, the man, 32 years old, the worker of dress company is pressed in Zibo City's architectural engineering, because of suffering from chronic aplastic anemia 8 years, successively goes ground hospitalizes such as Jinan, Beijing, Feicheng, Shijiazhuang, use up RMB eight, 90,000 yuan, all the time the commentaries on classics of not getting better only depending on repeatedly that blood transfusion earns a bare living, and came my institute's diagnosis and treatment on June 13rd, 93.Have a medical check-up: middle-aged male, lusterless complexion, the lip and nail color is light, and pale tongue is fat, and deep and weak pulse is unable.The blood test routine is shown: Hb45g/L RBC1.6 * 10
12/ L WBC1.7 * 10
9/ L PC35 * 10
9/ L, Western medicine diagnose: chronic aplastic anemia, tcm diagnosis: asthenia, blood disorder, dialectical: QI and blood is two loses, and gives oral beneficial marrow SHENGXUE WAN, each 2 ball 12g, day obeys three times, and cooperate stanozolol, vitamin E ball, Gai Tianli and be interrupted blood transfusion Supporting Therapy after four months, all diseases of patient alleviate, and the state of an illness is clearly better, have rosy cheeks, the whole body is strong, the bimester of the beneficial marrow SHENGXUE WAN treatment of clothes after, check routine blood test result: Hb115g/L RBC3.85 * 10
12/ L WBC4.5 * 10
9/ L RC1.2%PC87 * 10
9/ L follows up a case by regular visits to and did not have recurrence in 1 year.
Embodiment one: most preferred embodiment
Radix Ginseng Rubra 15, the Radix Astragali 50, Rhizoma Atractylodis Macrocephalae (parched) 15, Fructus Corni 20, Colla Plastri Testudinis 20, Carapax Trionycis 20, Fructus Ligustri Lucidi 30, Radix Rehmanniae Preparata 30, Radix Morindae Officinalis 15, Cortex Cinnamomi 6, Herba Epimedii 18, Colla cornus cervi 20, Radix Angelicae Sinensis 20, Colla Corii Asini 20, Caulis Spatholobi 30, Herba Agrimoniae 30, Radix Notoginseng 5, Indigo Naturalis 4.
Each medicine of distinguishing the flavor of is ground into carefully not, and by traditional Chinese patent medicine concocting method, processing is concocted, and honey is combined into ball, and the heavy 6g of every ball whenever closes 10 balls dress.
The beneficial marrow SHENGXUE WAN made from above-mentioned Chinese medicine has significant curative effect to treatment MDS disease and all kinds of anemia.
Embodiment two: the best constituent of embodiment one selects for use amount ranges of the present invention all can.
Embodiment three: make pill with following medicine
Radix Ginseng Rubra 15, Rhizoma Dioscoreae 15, Poria 15, Fructus Corni 20, Colla Plastri Testudinis 20 (or Carapax et Plastrum Testudinis 30), Carapax Trionycis 20, Rhizoma Polygonati 20, Fructus Lycii 30, Radix Morindae Officinalis 15, Semen Cuscutae 18, Rhizoma Curculiginis 15, Colla cornus cervi 20, Radix Polygoni Multiflori 15, Radix Angelicae Sinensis 20, Caulis Spatholobi 30, Herba Agrimoniae 30, the Pseudobulbus Bletillae (Rhizoma Bletillae) 15, Hedyotidis Diffusae 45.
Embodiment four: Radix Ginseng Rubra 20, the Radix Astragali 10, Rhizoma Atractylodis Macrocephalae (parched) 20, Rhizoma Dioscoreae 10, Fructus Corni 30, Colla Plastri Testudinis 10, Carapax Trionycis 30, Fructus Ligustri Lucidi 20, two mulberry 30, Herba Ecliptae 10, Radix Morindae Officinalis 20, Cortex Cinnamomi 3, Semen Cuscutae 10, Rhizoma Curculiginis 10, Colla cornus cervi 10, Radix Angelicae Sinensis 10, Arillus Longan 20, Caulis Spatholobi 30, Herba Agrimoniae 10, Radix Rubiae 10, Nodus Nelumbinis Rhizomatis 10.
Embodiment five:
Radix Ginseng Rubra 5, the Radix Astragali 60, Rhizoma Dioscoreae 30, Fructus Corni 10, Carapax et Plastrum Testudinis 30, Carapax Trionycis 10, Rhizoma Polygonati 10, Fructus Lycii 10, Radix Ophiopogonis 10, Radix Morindae Officinalis 15, Semen Cuscutae 30, Rhizoma Curculiginis 20, Colla cornus cervi 10, Colla Corii Asini 10, Radix Polygoni Multiflori 15, Arillus Longan 10, Caulis Spatholobi 10, Herba Agrimoniae 20, brown charcoal 10, Herba Scutellariae Barbatae 20, Rhizoma Polygoni Cuspidati 10, Pseudobulbus Cremastrae Seu Pleiones 10.
Claims (3)
1, a kind of beneficial marrow hemopoietic Chinese medicine preparation is characterized in that it is to be made by following parts by weight of traditional Chinese medicines material:
Radix Ginseng Rubra 5~20 or Radix Codonopsis 10~30, the Radix Astragali 10~60, Rhizoma Atractylodis Macrocephalae (parched) 5~20, Fructus Corni 10~30, Colla Plastri Testudinis 10~20 or Carapax et Plastrum Testudinis 10~30, Carapax Trionycis 10~30, Fructus Ligustri Lucidi 10~30, Radix Rehmanniae Preparata 10~30, Radix Morindae Officinalis 10~20, Cortex Cinnamomi 3~10, Herba Epimedii 10~30, Colla cornus cervi 10~20 or Cornu Cervi Pantotrichum 5~10, Radix Angelicae Sinensis 10~30, Colla Corii Asini 10~20, Caulis Spatholobi 10~30, Herba Agrimoniae 10~30, Radix Notoginseng 2~10, Indigo Naturalis 2~6.
2, Chinese medicine preparation according to claim 1, it is characterized in that in parts by weight, make by Radix Ginseng Rubra 15, the Radix Astragali 50, Rhizoma Atractylodis Macrocephalae (parched) 15, Fructus Corni 20, Colla Plastri Testudinis 20, Carapax Trionycis 20, Fructus Ligustri Lucidi 30, Radix Rehmanniae Preparata 30, Radix Morindae Officinalis 15, Cortex Cinnamomi 6, Herba Epimedii 18, Colla cornus cervi 20, Radix Angelicae Sinensis 20, Colla Corii Asini 20, Caulis Spatholobi 30, Herba Agrimoniae 30, Radix Notoginseng 5, Indigo Naturalis 4.
3, Chinese medicine preparation according to claim 1 and 2 is characterized in that dosage form is a pill.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN95110503A CN1062144C (en) | 1995-06-08 | 1995-06-08 | Yisuishengxue chinese medicine preparation for tonifying marrow and promoting generation of blood |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN95110503A CN1062144C (en) | 1995-06-08 | 1995-06-08 | Yisuishengxue chinese medicine preparation for tonifying marrow and promoting generation of blood |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1137393A CN1137393A (en) | 1996-12-11 |
CN1062144C true CN1062144C (en) | 2001-02-21 |
Family
ID=5077879
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN95110503A Expired - Fee Related CN1062144C (en) | 1995-06-08 | 1995-06-08 | Yisuishengxue chinese medicine preparation for tonifying marrow and promoting generation of blood |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1062144C (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100353969C (en) * | 2006-01-26 | 2007-12-12 | 周伟 | Medicine for treating aplastic anemia |
CN102406757A (en) * | 2011-11-28 | 2012-04-11 | 河南科技大学第一附属医院 | Traditional Chinese medicine capsule for treating myelodysplastic syndrome and its manufacturing method |
Families Citing this family (51)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1084203C (en) * | 1999-04-26 | 2002-05-08 | 刘祖文 | Health-care tortoise-turtle-pollen food and its preparing process |
CN1086141C (en) * | 1999-11-03 | 2002-06-12 | 郝忠礼 | Medicine for treating early-stage hepatocirrhosis and its preparation |
US20090004300A1 (en) * | 2004-09-30 | 2009-01-01 | Ai Ja Lee | Method and Composition for Enhancing Fertility |
CN101361858B (en) * | 2008-09-28 | 2011-04-06 | 袁六妮 | Medicine for treating aplastic anemia |
CN101401905B (en) * | 2008-11-10 | 2011-01-26 | 陈燕 | Chinese medicinal composition for treating aplastic anemia |
CN102008647B (en) * | 2009-09-09 | 2011-12-14 | 刘皇琼 | Traditional Chinese medicine for treating lymphangioleiomyomatosis and preparation method thereof |
CN101953943A (en) * | 2010-09-21 | 2011-01-26 | 王兴启 | Traditional Chinese medicine for treating chronic aplastic anemia |
CN102228563B (en) * | 2011-06-22 | 2012-07-25 | 莫忆鸣 | Traditional Chinese medicine preparation for treating paroxysmal nocturnal hemoglobinuria |
CN102319338B (en) * | 2011-09-27 | 2013-04-17 | 中国中医科学院西苑医院 | Chinese medicinal medicament for treating myelodysplastic syndrome (MDS) by mainly using natural indigo and realgar and preparation method of Chinese medicinal preparation |
CN102441126B (en) * | 2011-12-07 | 2013-07-10 | 赵戎 | Traditional Chinese medicine liquor with functions of blood enriching and yin nourishing |
CN102552568B (en) * | 2011-12-18 | 2014-09-17 | 贺光民 | Chinese medicine preparation for curing leukemia and aplastic anemia |
CN103110675A (en) * | 2012-02-14 | 2013-05-22 | 甘肃创兴生物工程有限责任公司 | Soft capsule for improving alimentary anemia and preparation method thereof |
CN102600289B (en) * | 2012-03-12 | 2013-05-15 | 王锦生 | Pure Chinese herba preparation for treating leukemia, preparation method and taking method of pure Chinese herba preparation |
CN102727746A (en) * | 2012-05-31 | 2012-10-17 | 固镇县中医院 | Chinese herbal decoction for treating qi-blood deficiency type thrombocytopenia |
CN103893543A (en) * | 2012-12-27 | 2014-07-02 | 师秀玉 | Ginseng antler anti-tuberculosis powder |
CN103055147B (en) * | 2013-01-08 | 2015-10-28 | 辽宁中医药大学 | That treats chronic aplastic anemia sticks medicine and preparation method thereof |
CN103055085B (en) * | 2013-02-13 | 2014-09-03 | 黄晶晶 | Traditional Chinese medical preparation for treating iron-deficiency anemia |
CN103316213B (en) * | 2013-06-08 | 2015-05-06 | 徐瑞荣 | Qilianyisui detoxification particles and preparation method thereof |
CN103505679B (en) * | 2013-08-30 | 2015-05-20 | 杜丽娟 | Drug for treating blood diseases, preparation method, and applications thereof |
CN103638303A (en) * | 2013-12-19 | 2014-03-19 | 青岛友铭辰生物技术有限公司 | Traditional Chinese medicine composition for treating anemia |
CN103736038B (en) * | 2014-02-19 | 2016-01-20 | 段寒 | Treat leukemic Chinese medicine composition, its preparation and application |
CN104027432B (en) * | 2014-05-23 | 2016-01-13 | 烟台瑞智生物医药科技有限公司 | A kind of Chinese medicine for the treatment of deficiency of kidney-QI pattern of syndrome preceeded menorrhea |
CN104013786B (en) * | 2014-06-10 | 2017-07-21 | 夏继云 | A kind of Chinese medicine composition for treating alpastic anemia |
CN104056202A (en) * | 2014-07-03 | 2014-09-24 | 吴晓青 | Traditional Chinese medicine for lowering blood viscosity and preparing method thereof |
CN104096104A (en) * | 2014-07-11 | 2014-10-15 | 王永欣 | Traditional Chinese medicine preparation for treating chronic leukemia |
CN104096077A (en) * | 2014-07-22 | 2014-10-15 | 孙喜范 | Traditional Chinese medicine for treating anemia |
CN104248743A (en) * | 2014-07-24 | 2014-12-31 | 董巧凤 | Oral administration medicament for treating thalassemia |
CN104352651A (en) * | 2014-11-12 | 2015-02-18 | 王洪强 | Oral administration medicine for diminishing inflammation and arresting bleeding for department of gynecology and obstetrics |
CN104800724B (en) * | 2015-04-20 | 2016-02-03 | 青岛市中心医院 | Improve the medicine of toxicity after chemotherapy of tumors |
CN104906470A (en) * | 2015-06-23 | 2015-09-16 | 吉布强 | Traditional Chinese medicine oral liquid for relieving acute leukemia and preparation method thereof |
CN104984027A (en) * | 2015-08-06 | 2015-10-21 | 徐冰洁 | Chinese materia medica preparation for treating myelodysplastic syndrome and preparation method thereof |
CN105106713A (en) * | 2015-09-16 | 2015-12-02 | 许建成 | Traditional Chinese medicine preparation for treating chronic aplastic anemia |
CN105362762A (en) * | 2015-12-02 | 2016-03-02 | 钊桂英 | Preparation for treating leukemia and preparing method thereof |
CN105362690A (en) * | 2015-12-02 | 2016-03-02 | 钊桂英 | Preparation for treating leukemia and preparing method thereof |
CN105362848A (en) * | 2015-12-02 | 2016-03-02 | 钊桂英 | Traditional Chinese medicine composition for treating leukemia and preparation method thereof |
CN105327194A (en) * | 2015-12-12 | 2016-02-17 | 徐士杰 | Medicine for treating anemia and preparing method thereof |
CN105663684A (en) * | 2016-02-29 | 2016-06-15 | 张坚斌 | Medicine for treating aplastic anemia |
CN105816824A (en) * | 2016-06-05 | 2016-08-03 | 曹兰 | Traditional Chinese medicine for treating chronic aplastic anemia |
CN106360668A (en) * | 2016-08-26 | 2017-02-01 | 凤阳瑞诚食品科技有限公司 | Nourishing food for nourishing heart and quieting spirit |
CN107260890A (en) * | 2017-08-04 | 2017-10-20 | 绿都中草药研发中心(北京)有限公司 | A kind of compound quick-acting is enriched blood blood-forming agent and application |
CN107397909A (en) * | 2017-08-30 | 2017-11-28 | 夏季 | A kind of medicine for treating alpastic anemia and preparation method thereof |
CN107753638B (en) * | 2017-11-03 | 2020-11-24 | 深圳市剡溪堂医药科技有限公司 | Medicine for promoting bone marrow hematopoiesis and preparation method and application thereof |
CN107913373A (en) * | 2017-11-28 | 2018-04-17 | 袁仕忠 | A kind of Chinese medicine composition and application for being used to treat hematologic malignancy |
CN107929481A (en) * | 2017-12-26 | 2018-04-20 | 王保健 | A kind of production method of tortoise deer life plate medicine |
CN108324903A (en) * | 2018-05-17 | 2018-07-27 | 重庆跃龙生物制药有限公司 | Treat the Chinese medicine composition and the preparation method and application thereof of anaemia |
CN109620929A (en) * | 2019-01-21 | 2019-04-16 | 谈发金 | A kind of green blood traditional Chinese medicine oral liquid and its preparation method and application |
CN112546190B (en) * | 2020-12-30 | 2022-06-17 | 长春中医药大学 | Traditional Chinese medicine composition for treating myelodysplastic syndrome, preparation method and application thereof, and honeyed pills |
CN112656905A (en) * | 2021-02-01 | 2021-04-16 | 苏州大学附属第一医院 | Composition for treating deficiency of qi and blood and preparation method and application thereof |
CN113908249A (en) * | 2021-12-06 | 2022-01-11 | 金红 | A Chinese medicinal composition with anticancer effect, and its preparation method |
CN114588214B (en) * | 2022-03-15 | 2022-11-15 | 东莞市中医院 | Composition and granules for improving bone marrow suppression after chemotherapy and preparation method |
CN115779049B (en) * | 2022-10-24 | 2024-04-12 | 中国农业大学 | Traditional Chinese medicine composition for chemotherapy induced myelosuppression as well as preparation and application thereof |
-
1995
- 1995-06-08 CN CN95110503A patent/CN1062144C/en not_active Expired - Fee Related
Non-Patent Citations (3)
Title |
---|
《中华血液血杂志》1984年第5卷第2期 1984.1.1 于材声等,中药生髓补血方治疗慢性再生障碍性贫血22例的近期疗效观察 * |
《中华血液血杂志》1984年第5卷第2期 1984.1.1 于材声等,中药生髓补血方治疗慢性再生障碍性贫血22例的近期疗效观察;《中西医结合杂志》1990年第10卷第1期 1990.1.1 王镜等,中药为主治疗再生障碍性贫血78例 * |
《中西医结合杂志》1990年第10卷第1期 1990.1.1 王镜等,中药为主治疗再生障碍性贫血78例 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100353969C (en) * | 2006-01-26 | 2007-12-12 | 周伟 | Medicine for treating aplastic anemia |
CN102406757A (en) * | 2011-11-28 | 2012-04-11 | 河南科技大学第一附属医院 | Traditional Chinese medicine capsule for treating myelodysplastic syndrome and its manufacturing method |
CN102406757B (en) * | 2011-11-28 | 2015-03-04 | 河南科技大学第一附属医院 | Traditional Chinese medicine capsule for treating myelodysplastic syndrome and its manufacturing method |
Also Published As
Publication number | Publication date |
---|---|
CN1137393A (en) | 1996-12-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1062144C (en) | Yisuishengxue chinese medicine preparation for tonifying marrow and promoting generation of blood | |
CN1169541C (en) | Medicine for treating rheumatoid arthritis | |
CN1186071C (en) | Medicines composition for treating chronic heart failure and its prepn | |
CN103356961B (en) | Traditional Chinese medicinal composition for treating amenorrhoea | |
CN100998851A (en) | Chinese medicinal preparation for curriculum of physical and fatigue reducing | |
CN101147791B (en) | Traditional Chinese medicine preparation for enriching blood and its preparation method | |
CN1062157C (en) | Hepatitis B curing toxin-dissipating pill | |
CN102743540A (en) | Combined blood sugar-reduction formula | |
CN1772152A (en) | Chinese medicine prepn for regulating menstruation and treating sterility | |
CN1772196A (en) | Heart failure regulating Chinese medicine | |
CN1332702C (en) | Medicine for treating psoriasis | |
CN1569107A (en) | Medicine for treating female chronic fatigue syndrome and its preparing process | |
CN1186687A (en) | Cancer preventing curing medicine series and its preparation | |
CN102988616A (en) | Chinese medicinal composition for treating anemia | |
CN102335336A (en) | Traditional Chinese medicine for treating lupus sebaceus | |
CN1291504A (en) | Medicine for treating cirrhosis ascites | |
CN103071079B (en) | Traditional Chinese medicinal composition for treating prurigo nodularis | |
CN104435545A (en) | Traditional Chinese medicine preparation for treating leucopenia caused by benzene poisoning | |
CN101549057A (en) | Chinese medicine composition for curing hyperlipemia, cerebral arteriosclerosis and ischemic apoplexy and method of preparing the same | |
CN101062236A (en) | Astragalus radix pseudostell oral liquid | |
CN1052914C (en) | Suyuwan pill for curing leucoderma | |
CN1271590A (en) | Medical capsule for curing aplastic anemia and its preparing process | |
CN1144681A (en) | Strong kidney tonic preparation | |
CN101804159B (en) | Traditional Chinese medicine preparation for treating aplastic anemia | |
CN101264260A (en) | Medicaments assembly for tonifying kidney and replenishing essence, strengthening spleen and benefiting qi and preparation thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C06 | Publication | ||
PB01 | Publication | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C19 | Lapse of patent right due to non-payment of the annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |